A detailed history of Pathway Financial Advisers, LLC transactions in Stryker Corp stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 57 shares of SYK stock, worth $20,307. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57
Previous 58 1.72%
Holding current value
$20,307
Previous $19.5 Million 6.42%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$315.94 - $371.96 $315 - $371
-1 Reduced 1.72%
57 $20.7 Million
Q2 2024

Aug 20, 2024

BUY
$324.3 - $354.67 $324 - $354
1 Added 1.75%
58 $19.5 Million
Q1 2024

May 29, 2024

BUY
$293.94 - $358.71 $16,754 - $20,446
57 New
57 $20.4 Million
Q3 2023

Jul 19, 2024

BUY
$266.54 - $302.43 $266 - $302
1 Added 1.14%
89 $24.2 Million
Q4 2022

Jul 19, 2024

BUY
$205.51 - $253.93 $6,370 - $7,871
31 Added 54.39%
88 $21.5 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $135B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Pathway Financial Advisers, LLC Portfolio

Follow Pathway Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisers, LLC with notifications on news.